Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine

PHASE1/PHASE2UnknownINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
TetanusDiphtheriaWhooping Cough
Interventions
BIOLOGICAL

Biological: GC3111 vaccine

0.5mL, Intramuscular

BIOLOGICAL

Biological: Boostrix® vaccine

0.5mL, Intramuscular

Trial Locations (5)

1544-9004

Incheon St. Mary's Hospital Catholic Univ., Incheon

301-723

The Catholic Univ. of Korea Daejeon St.Mary's Hospital, Daejeon

Unknown

The Catholic Univ.of Korea Bucheon St.Mary's Hospital, Gyeonggi-do

The Catholic Univ.of Korea Uijeongbu St.Mary's Hospital, Gyeonggi-do

The Catholic Univ.of Korea Yeouido St.Mary's Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Green Cross Corporation

INDUSTRY